Страна: Армения
Язык: английский
Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում
fluconazole
Fareva Amboise
J02AC01
fluconazole
2mg/ml
solution for i/v infusion
glass vial 50ml
Prescription
Registered
2018-12-24
spcde-0v52df-i-0 1 30.09.2022 PFIZER ((logo)) Diflucan ® IV 2 mg/ml SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE MEDICINAL PRODUCT Diflucan ® IV 2 mg/ml solution for infusion 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains 2 mg of fluconazole. 1 vial with 50 ml solution for infusion contains 100 mg fluconazole. 1 vial with 100 ml solution for infusion contains 200 mg fluconazole. 1 vial with 200 ml solution for infusion contains 400 mg fluconazole. Excipient with known effect: Each ml contains 9 mg sodium chloride (equivalent to 0.154 mmol sodium) (see section 4.4). For the full list of excipients, see section 6.1. 3. PHARMACEUTICAL FORM Solution for infusion Clear, colourless solution with no visible particles. 4. CLINICAL PARTICULARS 4.1 THERAPEUTIC INDICATIONS Diflucan is indicated in the following fungal infections (see section 5.1). Diflucan is indicated in adults for the treatment of: Cryptococcal meningitis (see section 4.4). Coccidioidomycosis (see section 4.4). Invasive candidiasis. Mucosal candidiasis including oropharyngeal, oesophageal candidiasis, candiduria and chronic mucocutaneous candidiasis. Chronic oral atrophic candidiasis (denture sore mouth) if dental hygiene or topical treatment are insufficient. Diflucan is indicated in adults for the prophylaxis of: Relapse of cryptococcal meningitis in patients with high risk of recurrence. Relapse of oropharyngeal or oesophageal candidiasis in patients infected with HIV who are at high risk of experiencing relapse. Candidal infections in patients with prolonged neutropenia (such as patients receiving chemotherapy with haematological malignancies or spcde-2v54df-i-0 2 30.09.2022 patients receiving Hematopoietic Stem Cell Transplantation [see section 5.1]). Diflucan is indicated in term newborn infants, infants, toddlers, children, and adolescents aged from 0 to 17 years old: Diflucan is used for the treatment of mucosal candidiasis (oropharyngeal, oesophageal), invasive candidiasis, cryptococcal meningi Прочитать полный документ